Cargando…
Strategies of Targeting Inflammasome in the Treatment of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ dysfunction resulting from the production of multiple autoantibodies and adaptive immune system abnormalities involving T and B lymphocytes. In recent years, inflammasomes have been recognized as an important...
Autores principales: | Liu, Yaling, Tao, Xinyu, Tao, Jinhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157639/ https://www.ncbi.nlm.nih.gov/pubmed/35664004 http://dx.doi.org/10.3389/fimmu.2022.894847 |
Ejemplares similares
-
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
por: Becker, Yann, et al.
Publicado: (2019) -
HMGB1 in Systemic Lupus Erythematosus
por: Liu, Tianye, et al.
Publicado: (2020) -
Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus
por: Gottschalk, Timothy A., et al.
Publicado: (2015) -
Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
por: Mizui, Masayuki, et al.
Publicado: (2018) -
Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)